GC Cell Corporation (KOSDAQ:144510)
25,250
-200 (-0.79%)
At close: Mar 20, 2026
GC Cell Market Cap
GC Cell has a market cap or net worth of 379.44 billion as of March 20, 2026. Its market cap has increased by 4.99% in one year.
Market Cap
379.44B
Enterprise Value
462.18B
Revenue
165.52B
Ranking
n/a
PE Ratio
n/a
Stock Price
25,250.00
Market Cap Chart
Since June 23, 2016, GC Cell's market cap has decreased from 507.65B to 379.44B, a decrease of -25.26%. That is a compound annual growth rate of -2.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 379.44B | 1.61% |
| Dec 30, 2025 | 373.42B | 4.85% |
| Dec 30, 2024 | 356.14B | -47.90% |
| Dec 28, 2023 | 683.53B | -3.46% |
| Dec 29, 2022 | 708.04B | -55.94% |
| Dec 30, 2021 | 1.61T | 65.31% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Jun 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Green Cross Holdings | 634.72B |
| SillaJen | 495.89B |
| Genomictree | 478.78B |
| Anterogen.Co.,Ltd. | 422.76B |
| BINEX | 400.33B |
| JETEMA, | 315.74B |
| Bioneer | 307.66B |
| HLB Therapeutics | 265.79B |